newsfilter
← Interviews
a16z24 min

Big Ideas in 2024: Democratizing “Miracle Drugs” with Julie Yoo

Julie Yoo

Interview, Fireside Chat

Andreessen Horowitz partners project that democratizing miracle drugs like GLP-1s and cell therapies will define 2024, driven by a massive eligible U.S. population and the urgent need to prevent healthcare system insolvency. While these programmable medicines offer curative potential, their current exorbitant costs and complex logistics create severe friction in financing, manufacturing, and clinical operations. The industry is responding with 2024-focused innovations in industrialized biomanufacturing, fintech risk-spreading instruments, and real-world data infrastructure, all while awaiting necessary regulatory adaptations from the FDA and CMS.